IRCT201106031556N22已完成2 期
Memantine as adjuvant therapy in the treatment of severe OCD: a double blind randomized trial Effect of
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: 1-Age between 18-60, 2-Diagnosis of OCD based on DSM IV 3 , Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale-
排除标准
- •1- Substance dependence,2- IQ <70,3-any other mental disorder on axis I, 4-Any serious cardiac, renal or hepatic disease ,5- receiving psychotropic medications during the last 6 weeks 6- pregnancy orbreast feeding 7-rising liver transaminases to three times the upper limit of normal or higher
研究者
相似试验
已完成
3 期
se of memantin in treatment of adult with attention deficit hyperactivity disorderAdult ADHD (Attention-deficit hyperactivity disorder ).Disturbance of activity and attentionIRCT2016053028182N1Kurdistan University of Medical science40
已完成
不适用
Efficacy of Memantine in bipolarBipolar disorder.Bipolar affective disorderIRCT2013091514676N1Vice chancellor for research, Kurdistan University of Medical Sciences40
招募中
不适用
Memantine for treatment of Obsessive-Compulsive DisorderObsessive-compulsive disorderIRCT20170123032145N4Iran University of Medical Sciences44
招募中
2 期
Amantadin as adjuvant therapy in the treatment of moderate to severe OCDObsessive-compulsive disorderObsessive- Cumpulsive Disorder.IRCT201705191556N99Tehran University of Medical Sciences50
已完成
3 期
adding memantine to treatment of schozophereniaSchizophreniaIRCT20180301038906N1Mashhad University of Medical Sciences60